TP53 and small cell lung carcinoma: Here, we present a case of spontaneous transformation from <i>EGFR</i>-mutant LUAD with loss of p53 and RB to EGFR expression-positive SCLC and neuroendocrine-differentiated LUAD, which was successfully treated with osimertinib.